Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population

Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population

Fifty five percent of the Pakistani population is still unvaccinated with the two-dose protocol of COVID-19 vaccines. This study was undertaken to determine the seroconversion rate and antibody titers following the two-dose BBIBP-CorV protocol, and to compare these variables in unvaccinated, COVID-1...

Full description

Bibliographic Details
Main Authors: Javeria Aijaz, Shakir Hussain, Fouzia Naseer, Fatima Kanani, Sabiha Anis, Samreen Sarfaraz, Saima Saeed, Hina Farooq, Saba Jamal
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
BBIBP-CorV
Sinopharm
COVID-19
Pakistan
pseudotyped
neutralizing
Online Access:https://www.mdpi.com/2076-393X/10/5/692

Similar Items

Similar Items